ArticleBMC cancer2023

Overall survival in patients with advanced non-small cell lung cancer with KRAS G12C mutation with or without STK11 and/or KEAP1 mutations in a real-world setting.

Cristina Julian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.